SCHEMBL8360384

SCHEMBL8360384

Bc1cc(-c2ccccn2)cn(-c2ccccn2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
GRIA1 P42261 1/20 0.44
GRIA3 P42263 1/20 0.44
PDE4D Q08499 1/20 0.44
GAA P10253 3/20 0.42
POLB P06746 3/20 0.42
TSHR P16473 2/20 0.42
COMT P21964 1/20 0.42
MAPT P10636 1/20 0.39
BRD4 O60885 1/20 0.38
CYP2A6 P11509 1/20 0.38
NOX4 Q9NPH5 1/20 0.37
NOX1 Q9Y5S8 1/20 0.37
CNR2 P34972 1/20 0.37
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CCR1 P32246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360380 0.86 GRIA1 (0.59) SMN1; SMN2GRIA1GRIA3PDE4DPOLB
SCHEMBL1886927 0.83 POLB (0.57) SMN1; SMN2GRIA1GRIA3PDE4DGAA
SCHEMBL8360778 0.81 CYP2A6 (0.51) SMN1; SMN2GRIA1GRIA3PDE4DTSHR
SCHEMBL1885107 0.76 SMN1; SMN2 (0.45) SMN1; SMN2GRIA1GRIA3PDE4DGAA
SCHEMBL1885465 0.75 GRIA1 (0.79) GRIA1GRIA3PDE4DGAAPOLB
SCHEMBL1879808 0.71 NOX4 (0.44) SMN1; SMN2GRIA1GRIA3PDE4DGAA
SCHEMBL1887704 0.70 GRIA1 (0.71) GRIA1GRIA3PDE4DPOLBCOMT
SCHEMBL10077186 0.69 GRIA1 (0.59) GRIA1GRIA3PDE4DBRD4CYP2A6
SCHEMBL1884948 0.69 GRIA1 (0.70) GRIA1GRIA3PDE4DGAAMAPT
SCHEMBL1882837 0.69 GRIA1 (0.59) GRIA1GRIA3PDE4DPOLBCOMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177520-A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors Eisai R&D Management Co., Ltd. (JP) 2010-04-21 EP disclosed
EP-2053041-A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease Eisai R&D Management Co., Ltd. (JP) 2009-04-29 EP disclosed
EP-1300396-B1 1,2-DIHYDROPYRIDINE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF EISAI R&D MAN CO LTD (JP) 2009-01-14 EP disclosed
EP-1465626-B1 PHARMACEUTICAL COMPOSITIONS (KIT) COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY (OR AN ANTIINFLAMMATORY) AGENT AND THEIR USES EISAI R&D MAN CO LTD (JP) 2008-09-03 EP disclosed
WO-2003047577-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY OR AN ANTIINFLAMMATORY AGENT AND THEIR USES EISAI CO LTD (JP) 2003-06-12 WO disclosed